CARsgen® U.S. Clinical Holds Lifted by FDA ...Middle East

SHANGHAI, Oct. 31, 2024 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announces that the U.S. Food and Drug Administration ("FDA") lifted the...

Hence then, the article about carsgen u s clinical holds lifted by fda was published today ( Friday 01/11/2024 - 04:49 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( CARsgen® U.S. Clinical Holds Lifted by FDA )

Also on site :

• Prominent Canadian Musician Says Gig Was Cancelled After Google AI Overview Wrongly Branded Him Sex Pest
• Goldman Sachs expects layoffs to keep rising—and says investors are punishing the stocks of companies that slash staff
• Tuya Smart Launches "Hey Tuya:" A Super AI Life Assistant Bringing Physical AI to Everyday Life